Rs2305160

Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin's lymphoma.

Variants in circadian genes and prostate cancer risk: a population-based study in China.

Correlation between circadian gene variants and serum levels of sex steroids and insulin-like growth factor-I.

NPAS2 and PER2 are linked to risk factors of the metabolic syndrome.

CLOCK is suggested to associate with comorbid alcohol use and depressive disorders.

ARNTL (BMAL1) and NPAS2 gene variants contribute to fertility and seasonality.